EL TROPISMO DEL VIH Y SU FENOTIPIFICACIÓN.

Autores/as

  • Humberto H. Lara Villegas Laboratorio de Bioseguridad Nivel III. Departamento de Inmunología y Virología. Facultad de Ciencias Biológicas. Universidad Autónoma de Nuevo León (Nuevo León, México)
  • Liliana del C. Ixtepan Turrent Laboratorio de Bioseguridad Nivel III. Departamento de Inmunología y Virología. Facultad de Ciencias Biológicas. Universidad Autónoma de Nuevo León (Nuevo León, México)
  • Cristina Rodríguez Padilla Laboratorio de Bioseguridad Nivel III. Departamento de Inmunología y Virología. Facultad de Ciencias Biológicas. Universidad Autónoma de Nuevo León (Nuevo León, México)

Resumen

El objetivo de nuestra investigación en el BL-3 empieza al enfocarnos para entender las interacciones especificas entre los componentes moleculares del VIH y las proteínas humanas .
Este proceso nos definirá cuales son los factores del huésped que son requeridos para una infección productiva. Un objetivo inmediato de esos estudios son el proveer con nuevas terapias para el desarrollo de nuevos medicamentos. Usando lo que hemos conocido sobre estos trabajos moleculares intentamos estudiar las interacciones moleculares del VIH y el sistema inmune del huésped .


Palabras clave : Tropismo , HIV, CD4, CXCR4, CCR5, Compuestos Arginino Aminoglicosidos , mutaciones , antiretrovirales

Tropism, HIV, CD4, CXCR4, CCR5, Arginine aminoglicosid, Mutations, Antiretroviral

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Barre-Sinoussi F, JC. Chermann ,F. Rey ,MT. Nugeyre ,S. Chamaret ,J. Gruest ,C. Dauguet ,C. Axler-Blin ,F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum and L. Montagnier 1983. Isolation of a Tlymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Science;220(4599):868-871

Gallo, RC, PS. Sarin, EP. Gelmann, M. Robert-Guroff, E. Richardson, VS. Kalyanaraman, D. Mann, GD. Sidhu, RE. Stahl, S. Zolla-Pazner, J. Leibowitch and M. Popovic. 1983 Isolation of

human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science;220(4599):865-867

Alkhatib G, CC. Broder and EA. Berger. 1996a. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J Virol.

(8):5487-5494

Alkhatib G, C. Combadiere, CC. Broder, Y. Feng, PE. Kennedy, PM. Murphy and EA. Berger. 1996b. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for

macrophage-tropic HIV-1. Science;272(5270):1955-1958.

Trkola A, T. Dragic, J. Arthos, JM. Binley, WC. Olson, GP. Allaway, C. Cheng-Mayer, J. Robinson, PJ. Maddon, and JP. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature;384(6605):184-187.

Wu L, NP. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, AA. Cardoso, E. Desjardin, W. Newman, C. Gerard and J. Sodroski.1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature.;384(6605):179-183.

Koot M., A.H.V. Vos, R.P.M. Keet,R.E.Y. de Goede, W. Dercksen, F.G. Terpstra, R.A. Coutinho, F. Miedema, and M. Tersmette 1992 HIV-1 biological phenotype in long-term infected individuals

evaluated with an MT-2 cocultivation assay. AIDS 6:49–54.

Asjo B., L. Morfeldt-Manson, J. Albert, G. Biberfeld, A. Karlsson, K. Lidman, and EM. Fenyo 1986 .Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV

infection. Lancet. ii:660–662.

Fenyo, E.M, L. Morfeldt-Manson, F. Chiodi, A. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Asjo, 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol. 62:4414–4419.

Tersmette M., R E. de Goede, B.J. Al, I.N. Winkel, R.A. Gruters, H.T. Cuypers, H.G. Huisman, and F. Miedema 1988 Differential syncytium-inducing capacity of human immunodeficiency virus

isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol, 62:2026–2032.

Alkhatib G,C.et al, Op. cit. 1996a

Alkhatib G,C.et al, Op. cit 1996b

Trkola A. et al, Op. cit

Wu L, et al, Op. cit

Furci L, G. Scarlatti and S. Burastero.1997. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5

allele. J Exp Med; 186: 455-460.

Trkola A, T. Dragic, and J. Arthos. 1996. CD4-dependent, antibody-sentive interactions between HIV-1 and its co-receptor CCR-5- Nature; 384 (6605): 814-817

Balfe P, Y. Churcher and M. Penny 1998. Association between a defective CCR-5 gene and progression to disease in HIV infection. AIDS Res Hum Retroviruses; 14: 1229-1234.

Gorry PR, C. Zhang, S. Wu, K. Kunstman, E. Trachtenberg, J. Phair, S. Wolinsky and D. Gabuzda. 2002 Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta

allele. Lancet. May 25;359(9320):1832-1834.

Moriuchi H, M. Moriuchi, C. Combadiere, PM. Murphy and AS. 1996 Fauci.CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1

replication in monocyte/macrophages Proc Natl Acad Sci U S A.;93(26):15341-15345.

Ahmed RK, B. Makitalo, K. Karlen, C. Nilsson, G. Biberfeld and R. Thorstensson. 2002 Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge. Clin Exp Immunol;129(1):11-18.

Trujillo JR, WK. Wang, TH. Lee and M. Essex. 1996 Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1. Virology.;217(2):613-617.

Doranz BJ., K. Grovit-Ferbas, MP. Sharron, SH. Mao, MB. Goetz, ES. Daar , RW. Doms and WA. O'Brien.1997 A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med.;186(8):1395-1400

Tamamura H, T. Murakami, M. Masuda, A. Otaka, W. Takada, T. Ibuka, H. Nakashima, M. Waki, A. Matsumoto and N. Yamamoto. 1994. Structure-activity relationships of an anti-HIV peptide,

T22. Biochem Biophys Res Commun.;205(3):1729-1735.

De Clercq E and D. Schols 2001.Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Antivir Chem Chemother.;12 Suppl 1:19-31

Daelemans D, D. Schols, M. Witvrouw, C. Pannecouque, S. Hatse, S. van Dooren, F. Hamy, T. Klimkait, E. de Clercq and AM.VanDamme .2000 A second target for the peptoid

Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. Mol Pharmacol.

(1):116-124.

Armand-Ugon M, ME. Quinones-Mateu , A. Gutierez, J. Barretina, J. Blanco, D. Schols, E. De Clercq, B. Clotet, JA. Este. 2003 Reduced fitness of HIV-1 resistant to CXCR4 antagonists. Antivir Ther;8(1):1-8.

De Clercq E. 2002 New developments in anti-HIV chemotherapy Biochim Biophys Acta.;1587(2- 3):258-275.

Litovchick A, A. Lapidot, M. Eisenstein, A. Kalinkovich and G. Borkow. 2001 Neomycin Barginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.

Biochemistry.;40(51):15612-15623.

Lapidot A., M. Eisenstein, A. Kalinkovich and G. Borkow, 2002 Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities, Antivir. Res. 53 (3): 26 Sp. Iss.

Borkow G., V. Vijayabaskar , HH. Lara, A. Kalinkovich and A. Lapidot,2003.Structure-activity relationship of neomycin, paromomycin and neamine- arginine conjugates, targeting HIV-1 gp120- CXCR4 binding step. Antiviral Res.;60(3):181-192.

Borkow G, HH. Lara and A. Lapidot . 2003. Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate. Biochem Biophys Res Commun.;312(4):1047-

Descargas

Publicado

2004-12-31

Cómo citar

Lara Villegas, H. H., Ixtepan Turrent, L. del C., & Rodríguez Padilla, C. (2004). EL TROPISMO DEL VIH Y SU FENOTIPIFICACIÓN. RESPYN Revista Salud Pública Y Nutrición, 5(4). Recuperado a partir de https://respyn.uanl.mx/index.php/respyn/article/view/138

Número

Sección

Artículo Original

Artículos más leídos del mismo autor/a